Posted in | News | Gold | Silver | Mining Business

Millrock Discovers Important New Zones of Mineralization at Willoughby Project

Millrock Resources Inc. is pleased to announce that sampling results have been reported by partner Sojourn Exploration Inc.,. Sojourn indicates in their press release that it has discovered important new zones of mineralization at the Willoughby Project, located in the Golden Triangle district of British Columbia, during the Company’s recent surface prospecting program. The new zones of bedrock mineralization are located in some of the freshly exposed bedrock revealed by recent retreat of glaciers and snowfields.

Sojourn reports that of the 60 bedrock and float random grab samples collected across the Willoughby property, 16 returned values in excess of 1 gram per tonne (g/t) gold, three of which returned values in excess of 5 g/t with a maximum value of 8.15 g/t. A shallowly west dipping, one-meter thick quartz sulfosalt shear vein was discovered and mapped over a 250-meter strike length. The vein lies below the historic Main Zone drill collars roughly parallel to the Main Zone. One-meter chip samples across the vein returned values of:

  • 3.88 g/t Au and 2.42 g/t Ag;
  • 1.93 g/t Au and 4.81 g/t Ag;
  • 2.76 g/t Au and 92.1 g/t Ag;
  • 1.87 g/t Au and 2.13 g/t Ag; and
  • 0.56 g/t Au and 1.24 g/t Ag.

A grab sample of locally derived sulfide talus down slope from the exposure returned 6.18 g/t Au and 206 g/t Ag. The shear vein pinches out to the south and is open to the north underneath the North Willoughby Icefall.

Sojourn also noted that there are indications of possible massive sulfide mineralization within limestone located in the northern section of the claim block. A talus grab sample of very angular, locally derived gossanous vuggy limestone returned a result of 17.25% zinc. This sample was collected from rubble crop on a ridge above the glaciers and very close to the summit.  It is coincident with a significant color anomaly around the summit. Investors are cautioned that this sample is a selective sample and is not necessarily representative of the mineralization hosted on the property.

Sojourn is earning a 100% interest in the Willoughby property from Millrock by making share issuances totaling 1,840,000 common shares and completing $2,000,000 in exploration over the next three years. Millrock holds a production royalty and certain milestone payments may be payable to a third party that vended the Willoughby claim to Millrock. Millrock managed the recent exploration program on behalf of Sojourn.

Quality Control – Quality Assurance
Millrock adheres to stringent Quality Assurance – Quality Control (QA/QC) standards. All samples were sent to the ALS Minerals Ltd. prep lab in Terrace, British Columbia for subsequent shipment and analysis at the ALS Minerals Ltd. North Vancouver, BC laboratory, a 17025:2005 certified facility. All samples were collected by Alaska Earth Sciences personnel under contract to Millrock and securely stored until delivery to ALS Minerals Terrace. At this early stage of exploration, Millrock and Sojourn is relying on the certified standards utilized by ALS Minerals as part of it analysis protocols. No QA/QC anomalies were noted in the analyses.

All results from blanks, standards and duplicates were reviewed and found to be accurate within acceptable tolerances for results obtained to date.

The scientific and technical information disclosed within this document has been reviewed and approved by Gregory A. Beischer, President, CEO and a director of Millrock Resources. Mr. Beischer is a Qualified Person as defined in NI 43-101.

Source: https://www.millrockresources.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.